Three patients with ANLL developed Fournier's gangrene as an early complication after allo-BMT (two cases) and auto-BMT (one case); two patients were in first CR, the third had resistant disease. Patients developed fever, perineal pain, swelling and blistering of the genital area. Pseudomonas aeruginosa was isolated from the lesions and patients received systemic antibiotic therapy, surgical debridement and medication with potassium permanganate solution. Two patients made a complete recovery although one died of sepsis. The third had progressive involvement of the abdominal wall and later died of leukemia. Early diagnosis of this disorder and prompt initiation of appropriate therapy can prevent progression of this acute necrotizing infection. Keywords: Fournier's gangrene; necrotizing fasciitis; bone marrow transplantation Fournier's gangrene (FG) is an acute severe necrotizing disease of the fascia, subcutaneous fat and skin caused by a combination of aerobic and anaerobic bacteria, and involves the lower parts of the genitourinary tract, anorectal soft tissue and genital skin.
Fournier's gangrene (FG) is an acute severe necrotizing disease of the fascia, subcutaneous fat and skin caused by a combination of aerobic and anaerobic bacteria, and involves the lower parts of the genitourinary tract, anorectal soft tissue and genital skin. [1] [2] [3] [4] [5] Fournier's gangrene usually involves male genitalia, but it has also been described in females.
2, 3 Schultz et al 6 suggest that Fournier's gangrene may be related to a form of localized vasculitis with histological evidence of hemorrhagic necrosis. A mortality rate of 30-50% has been reported; 2, 3, 6 predisposing factors include diabetes mellitus, perineal trauma or infection, chronic alcoholism, malignancies and an immunocompromised status. 3 Despite the severe immunodeficiency that occurs in patients who undergo bone marrow transplantation (BMT), 7 Fournier's gangrene has been described in only one case of autologous BMT (auto-BMT). 8 We report three further cases who developed FG in the early cytopenic post-transplant phase. Two had received an allogeneic A 41-year-old male, with ANLL in first hematological complete remission (CR), underwent allo-BMT from an HLA identical sibling donor. Pre-transplant tests showed normal renal and hepatic function; chest X-ray revealed evidence of a previous right pleuritis; ECG and echocardiography were normal. Performance status was good and clinical examination was negative. Conditioning consisted of busulphan (BU) and cyclophosphamide (CY). The patient received 2 × 10 8 /kg donor bone marrow cells; take was documented on day +11 from transplant. On day +4, he complained of chills and fever Ͼ38°C; physical examination showed genital erythema, pain, swelling and crepitation. Broad-spectrum systemic antibiotic therapy was started; white blood cell (WBC) and platelets counts were respectively 0.5 × 10 neal region and upper thighs and FG was diagnosed. His clinical parameters at this time are shown in Table 1 : Pseudomonas aeruginosa was isolated from blood, perineal areas, scrotal and abdominal skin. On day +11, systemic antibiotic therapy with imipenem at a dose of 1 g three times daily was started together with local potassium permanganate solution 0.01% and surgical debridement of the lesions. The fever disappeared within 24 h and his general condition improved. Systemic and topical treatment was continued for 4 weeks. At discharge from hospital skin and blood cultural tests were negative. Two weeks later, the patient entered another hospital because of fever and died from sepsis on day +90 from BMT, in complete hematological remission.
Case No. 2
A 26-year-old female with ANLL in early relapse after allo-BMT from an HLA-identical sibling donor, received peripheral blood stem cells (PBSC) collected from the same donor as a rescue after one cycle of standard chemotherapy. At the time of the procedure, her performance status was poor, although hepatic and renal parameters were normal. On day +7, fever of Ͼ38°C occurred and clinical examination showed redness and swelling of the right labium majorum. Two days later, the lesions reached the pubis and dusky discoloration of the skin was observed associated with ulceration and pain. Hematological and biochemical characteristics of the patient at this time are shown in Table 1 . Pseudomonas aeruginosa was isolated from the lesions and Fournier's gangrene was diagnosed. WBC count and platelets count were respectively 0.16 × 10 9 /l and 0.09 × 10 9 /l. Systemic therapy with amikacin 500 mg/12 h was started. The fever disappeared 2 days later but the pain and swelling spread to the anterior abdominal wall. Echography of the area showed an abscess of the right rectus Table 1 Clinical parameters and FG severity index according to Laor From Laor et al. 9 1995. AST/ALT = aspartate aminotransferase/alanine aminotransferase. abdominis ( Figure 2 ). Surgical debridement and local therapy with potassium permanganate solution 0.01% were given and systemic antibiotic therapy was continued. On day +40, microbiological examination of a swab from the cutaneous lesions and echography of the abdominal wall were negative. Despite topical antiseptic treatment and intravenous antibiotic therapy the skin lesions did not resolve completely. The patient died of leukemia on day +64 from BMT.
Case No. 3
A 25-year-old female with ANLL in first CR underwent auto-BMT. Conditioning consisted of BCNU, etoposide and Ara-C from day −5 to day −2. On day 0, she received 2.2 × 10 8 /kg unmanipulated cryopreserved autologous bone marrow cells. Fever Ͼ38°C appeared on day +2. Systemic antibiotic therapy with ceftazidime, gentamicin and teichoplanin was started without any improvement. On day +10, the WBC count and platelets count were respectively 0.6 × 10 9 /l and 0.23 × 10 9 . She complained of pain, edema, erythema and swelling of the perineal area. The skin lesions rapidly spread to the suprapubic region and became a necrotic ulcer. Cultures of the cutaneous lesions were positive for Pseudomonas aeruginosa. Therefore antibiotics were changed to imipenem and amikacin, and daily local potassium permanganate solution 0.01% was used, along with surgical debridement. Complete resolution of skin lesions occurred by day +27 and the patient was discharged. She is still well, in complete hematological remission at day +1230.
Discussion
Fournier's gangrene has been described as an infectious complication in genito-urinary disorders, hematological diseases and acquired immunodeficiency syndrome. Diabetes mellitus, advancing age, malignancy and alcoholism are frequently reported as contributing factors.
1-6,8,10-12
The first case of Fournier's gangrene associated with a hematological disease was described in 1983 by Patrizi et al. They reported one case of acute promyelocytic leukemia treated by conventional chemotherapy. 11 Seven other patients with hematological malignancies have subsequently been reported; 8, 12 they suffered from ANLL (three cases), ALL (two cases) and NHL (two cases). One, suffering from NHL in first relapse, had undergone auto-BMT and died of sepsis on day + 6 ( Table 2) . In all but one of six patients, cultures were positive for Pseudomonas aeruginosa.
Patients undergoing BMT are immunodeficient which favors bacterial, viral and fungal infection. Immunodeficiency is particularly severe in allo-BMT where it may be worsened by graft-versus-host disease (GVHD) prophylaxis Cause of death sepsis leukemia -sepsis + = denotes alive; BU/CY = busulphan/cyclophosphamide; BCNU/VP/ARA-C = 1, 3-bis-(2-chloroethyl)-1-nitrosurea/etoposide/cytosine-arabinoside.
and by GVHD itself. 13 Fournier's gangrene, however, has never been described in allo-BMT patients.
In our experience, Fournier's gangrene was observed in three severely immunocompromised patients in the cytopenic phase after BMT. Two were females and one a male: Fournier's gangrene has usually been described in males; in a series of 449 patients, only 63 were females.
2 Two of our patients had undergone allo-BMT from an HLA-identical related donor and the third an auto-BMT. In all our cases Pseudomonas aeruginosa was isolated from the skin, and in one case from the blood also. We promptly started systemic antibiotics together with surgical debridement and topical treatment. In two cases we observed complete resolution within 3 weeks (Table 2) ; one died later of sepsis. We suggest that in this last case the terminal event was related to the previous infection; antibiotic therapy and local medication may have improved the cutaneous lesions, but the infection is likely to have spread into the pelvis, producing a late fatal sepsis. The third patient (case No. 2) who had active hematological disease after transplantation, did not respond to therapy and developed an abscess of the anterior abdominal wall (Figure 2 ). In this case the disease status at transplant could have impaired the healing processes.
In this report, Pseudomonas aeruginosa was isolated in all three cases. Pseudomonas aeruginosa has been associated with Fournier's gangrene in some reports. 2, 4, 6, 10 It was isolated in five out of seven patients with hematological malignancies. 8, 11, 12 In the majority of cases, Fournier's gangrene involves mixed bacterial flora:
3 the infection is caused by aerobic and anaerobic organisms with low or moderate virulence. Anaerobic organisms were not identified by culture, but their presence should be suspected where crepitation is present. 3 Some authors suggest that steroids could be important in treating FG. 6 In our experience, only patients who had received allo-BMT were given steroids as GVHD prophylaxis, together with cyclosporin A. Radaelli et al 12 reported a case of Fournier's gangrene treated by hyperbaric oxygen therapy; the authors noticed an unexplained improvement in the lesions even if Pseudomonas aeruginosa was the only isolated bacterium. The use of hyperbaric oxygen is appropriate in Clostridium perfringens or other anaerobic infections, while it could enhance replication of oxygendependent organisms such as Pseudomonas aeruginosa. We cannot exclude presence of a mixed microbic flora in the case reported by Radaelli et al. 12 Laor et al 9 proposed a Fournier's gangrene severity index score based on body temperature, heart and respiratory rate, serum sodium, potassium, creatinine, bicarbonate, hematocrit and WBC count: a score Ͼ9 would be associated with a 75% probability of death. We had a score value of Ͼ13 in patient No. 1, who died of sepsis; the remaining patients had scores of 8 and 9, respectively ( Table 1) .
The diagnosis of FG in allo-BMT patients may be difficult. Fournier's gangrene may develop abruptly with perineal pain, swelling, redness and blistering of the skin. These clinical features may be suggestive of an acute form of GVHD; however, the absence of typical skin lesions on the palms and soles, presence of fever, timing (too early), and the early demarcated necrotic ulcers should suggest the correct diagnosis. The incidence of Fournier's gangrene in patients receiving BMT may well be higher and therapeutic attempts to control what appears to be GVHD could result in delay in instigating appropriate systemic antimicrobic therapy. Early diagnosis of this disorder and prompt initiation of appropriate local medication along with systemic antimicrobial therapy, may abrogate the natural history of the disease. Fournier's gangrene presenting as a genito-perineal necrotizing fasciitis, should be considered as a potential complication in ANLL patients after BMT.
